CT SE LLC has a total of 14 patent applications. Its first patent ever was published in 2009. It filed its patents most often in WIPO (World Intellectual Property Organization), EPO (European Patent Office) and United States. Its main competitors in its focus markets pharmaceuticals, biotechnology and measurement are CONARIS RES INST AG, NYMOX CORP and AGIRX LTD.
# | Country | Total Patents | |
---|---|---|---|
#1 | WIPO (World Intellectual Property Organization) | 5 | |
#2 | EPO (European Patent Office) | 3 | |
#3 | United States | 2 | |
#4 | Canada | 1 | |
#5 | China | 1 | |
#6 | Israel | 1 | |
#7 | India | 1 |
# | Industry | |
---|---|---|
#1 | Pharmaceuticals | |
#2 | Biotechnology | |
#3 | Measurement | |
#4 | Organic fine chemistry |
# | Technology | |
---|---|---|
#1 | Therapeutic chemical compounds | |
#2 | Medical preparations | |
#3 | Peptides | |
#4 | Steroids | |
#5 | Analysing materials |
# | Name | Total Patents |
---|---|---|
#1 | Prudent James R | 12 |
#2 | Hutchinson Charles R | 4 |
#3 | Shekhani Mohammed S | 3 |
#4 | Hutchinson Charles B | 3 |
#5 | Thorson Jon S | 3 |
#6 | Bollettieri Jill Hutchinson | 2 |
#7 | Jon S Thorson | 1 |
#8 | Jill Hutchinson Bollettieri | 1 |
#9 | James R Prudent | 1 |
Publication | Filing date | Title |
---|---|---|
CN103732259A | Extracellular targeted drug conjugates | |
WO2012122514A1 | Extracellular targeted drug conjugates | |
EP2320729A1 | Glycoside compounds and pharmaceutical compositions thereof |